Return to Article Details
Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
Download
Download PDF
https://mail.cellmolbiol.org/index.php/CMB
Themes by Openjournaltheme.com
Themes by Openjournaltheme.com